4. Sheth SG, Chopra Sanjive. Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults [Интернет].
5. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
6. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
7. Menke A, Casagrande S, Geiss L, et al. Prevalence of and trends in diabetes among adults in the United States, 1988-2012.
8. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction.
9. Там же.
10. Claria J, Nguyen BT, Madenci AL, et al. Diversity of lipid mediators in human adipose tissue depots.
11. Claria J, Dalli J, Yacoubian S, et al. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat.
12. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction.
13. White PJ, Arita M, Taguchi R, et al. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice.
14. Neuhofer A, Zeyda M, Mascher D, et al. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.
15. Hellmann J, Tang Y, Kosuri M, et al. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.
16. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction.
17. Там же.
18. Guyenet SJ, Carlson SE. Increase in adipose tissue linoleic acid of US adults in the last half century.
19. Surette ME, Koumenis IL, Edens MB, et al. Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects.
20. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production.
21. Manole, Bogdan A. “Effect of Alpha-Linolenic Acid on Global Fatty Oxidation in Adipocytes and Skeletal Muscle Cells” [honors thesis project]. University of Tennessee; 2011.
22. Ikemoto S, Takahashi M, Tsunoda N, et al. High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils.
23. Hill JO, Peters JC, Lin D, et al. Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats.
24. Flachs P, Rossmeisl M, Kuda O, et al. Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype.
25. Flachs P, Horakova O, Brauner P, et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat.
26. Hensler M, Bardova K, Jilkova ZM, et al. The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice.
27. Ruzickova J, Rossmeisl M, Prazak T, et al. Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue.
28. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans.
29. Azain MJ. Role of fatty acids in adipocyte growth and development.
